[Policy Recommendations] Four Perspectives on Advancing Measures for Idiopathic Normal Pressure Hydrocephalus (iNPH) (February 16, 2023)
date : 2/17/2023
Tags: Dementia
The Health and Global Policy Institute (HGPI) Dementia Policy Project formulated policy recommendations in dementia titled, “Four Perspectives on Advancing Measures for Idiopathic Normal Pressure Hydrocephalus (iNPH).” For details, please view the PDF provided bottom.
■Background of these recommendations
These recommendations regarding future measures for Idiopathic Normal Pressure Hydrocephalus (iNPH) were compiled as part of an FY2022 initiative from the Health and Global Policy Institute (HGPI) Dementia Policy Project titled, “Current Issues and Future Prospects for Idiopathic Normal Pressure Hydrocephalus (iNPH) Measures – Focusing on a Form of Dementia that Improves with Treatment.”
Projections show that the number of people living with dementia in Japan will soon exceed 7 million and hopes are high for the development of treatments that relieve the symptoms of dementia and address its underlying causes for better living later in life. Many diseases that cause dementia are considered difficult to treat, but iNPH is a form of dementia that improves with treatment. It is estimated that iNPH affects around 370,000 people, or about 5% of all people living with dementia. In recent years, we have also come to understand that iNPH often occurs alongside Alzheimer’s disease, the most common cause of dementia, so the actual number of iNPH cases likely exceeds estimates. There are many potential benefits to delivering the appropriate treatments to people with iNPH, such as longer life expectancies, fall prevention, and high returns in terms of health economics. As demonstrated by developments like the adoption of the “Research Survey on Structuring Healthcare for a Treatable Form of Dementia” as a Ministry of Health, Labour and Welfare (MHLW) Project for the Promotion of Well-Being for Elderly People in 2019, iNPH is becoming an important item on the policy agenda. However, there are scattered issues that must be addressed before iNPH treatments can be delivered to as many people as possible to improve their symptoms and elevate their quality of life. In light of these circumstances, HGPI has positioned iNPH as a key item on its agenda for dementia policy and has engaged with various parties related to iNPH including health professionals, representatives of academia and industry, and the parties most affected for multi-stakeholder discussions with industry, Government, academia, and civil society. Based on those discussions, we have formulated the following policy recommendations regarding necessary measures for iNPH with the objective of resolving the diverse issues described above with an all-of-society response.
■Policy recommendations
Perspective 1: Promoting measures to enhance multi-stakeholder awareness during each phase
- The need to provide information on iNPH and to broadly and actively disseminate treatment guidelines across medical departments
- The need to expand the scope of awareness campaigns to target long-term care professionals, welfare professionals, and private businesses that support elderly people in their everyday lives
- The need to train patient advocate leaders and provide support that energizes activities from civil society organizations, starting with patient advocacy organizations
Perspective 2: Building a healthcare provision system that achieves early intervention and high-quality diagnosis and treatment
- The need to establish pathways from initial observations to medical consultations to enhance early detection, diagnosis, and response
- The need to establish centers for iNPH diagnosis and treatment that are compatible with the characteristics of each community
- The need to strengthen collaboration that spans hospitals, clinics, and multiple medical and long-term care professions to establish seamless postoperative follow-up systems
Perspective 3: Establishing a sustainable and innovative research environment that can respond to diverse needs
- The need to secure continuous funding and to drive growth in domestic iNPH research over the medium to long term
- The need to promote AI utilization, interdisciplinary joint research, international data sharing, and patient and public involvement (PPI) in research
Perspective 4: Exercising political leadership to ensure necessary measures are implemented in a stable and reliable manner
- The need to mention iNPH in national strategies, starting with the National Framework for Promotion of Dementia Policies
- The need to raise awareness toward iNPH in the legislature and to demonstrate leadership to advance future policies
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)